Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Acquisition of Lideta Hälsovård
Mandate

Acquisition of Lideta Hälsovård

November 10, 2017 M&A

Vinge is advising Nordstjernan in conjunction with the acquisition of a majority of the shares in Lideta Hälsovård.

Lideta conducts primary care via 15 centres in Stockholm and in southern Sweden. The company has grown quickly since it was founded in 2001 by doctor Simon Larsson and currently has 93 000 listed patients, 350 employees and a turnover of approximately MSEK 500.

The transaction is conditional upon approval by the relevant competition authorities, which is expected during the fourth quarter of 2017.

Vinge’s team consisted of partners Johan Winnerblad and Kristina Ekberg, associates Samra Baytar, Johanna Wiberg and Marion Kronberg. Grant McKelvey and Xandra Ståhlberg provided competition law advice.

Related

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge has advised Skeptiva AB in connection with its financing round

 Skeptiva is developing the next generation of cybersecurity defenses against fraud. The company has developed an AI application that detects attacks and alerts users in real time.
March 11, 2026

Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB

 Good Solutions Sweden AB (”Good Solutions”) provides software that helps factories identify and reduce production losses. The software converts data from machines and operators into insights that can be used to streamline production and increase profitability.
March 11, 2026